ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 20 analysts with an average price target of $28.23. This is a potential upside of $6.92 (32.47%) from yesterday's end of day stock price of $21.31.

ACADIA Pharmaceuticals's activity chart (see below) currently has 502 price targets and 340 ratings on display. The stock rating distribution of ACAD is 24.32% HOLD, 72.97% BUY and 2.7% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.44% with an average time for these price targets to be met of 257.41 days.

Highest price target for ACAD is $40, Lowest price target is $17, average price target is $28.89.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 28-Sep-2025. First documented stock forecast 05-May-2013.

Currently out of the existing stock ratings of ACAD, 9 are a HOLD (24.32%), 27 are a BUY (72.97%), 1 are a SELL (2.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$33

$11.2 (51.38%)

$34

10 days ago
(28-Sep-2025)

8/13 (61.54%)

$11.68 (54.78%)

113

Buy

$28

$6.2 (28.44%)

$30

15 days ago
(23-Sep-2025)

0/10 (0%)

$6.74 (31.70%)

Buy

$39

$17.2 (78.90%)

$35

28 days ago
(10-Sep-2025)

7/12 (58.33%)

$14.8 (61.16%)

671

Buy

$39

$17.2 (78.90%)

$32

1 months ago
(08-Sep-2025)

1/5 (20%)

$14.16 (57.00%)

349

Hold

$24

$2.2 (10.09%)

$23

2 months 2 days ago
(06-Aug-2025)

10/13 (76.92%)

$-0.4 (-1.64%)

157

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 257.41 days on average for the stock forecasts to be realized with a an average price target met ratio 65.44

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 8 price targets and 6 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $38.2

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Chris Howerton with lowest potential downside - -$6.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?